Emeis shares bounce back above €10 ahead of Q3 activity update
The nursing home and clinic operator continues its recovery started the previous day, in a Paris market oriented upwards. The group is unveiling today its third quarter activity, following a turbulent autumn for the stock.
A rebound that leaves the stock far from its medium-term averages
Emeis rises 3.08% to €10.39, versus a CAC 40 gaining 1.1%. The movement extends Wednesday's recovery, when the stock climbed back above €10, a threshold lost at the end of October at a one-year low.
The price is above its 20-day moving average (gap of 3.49%), but remains below its 50-day moving average (-9.57%) and its 200-day moving average (-23.09%), which gives a measure of the road ahead.
Performance figures tell the same story: +4.84% over the week, but -23.6% over three months. The RSI at 46 is neutral, far from the oversold level of 20 observed in early October.
Third quarter activity update published this Thursday
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The group is communicating today its third quarter 2026 activity. During the first half results, published on July 29, 2026, management had indicated that they allowed it to raise its 2026 guidance, with the trend since the start of the year exceeding its initial expectations. This increase constitutes the company's last quantified reference before today's activity update.
On the stock market, Emeis shares are trading within a support level at €9.75 and a resistance level at €12.45, two benchmarks that have framed the price for several weeks. The stock ranks at this stage in the first half of the SBF 120 during the session, which is gaining 1.1%.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 3 011 millions d'euros
Quarterly revenue: 3 011 millions d'euros
EBITDA: 461 millions d'euros
EBITDA margin: 15,3 %
Net income: -40,4 millions d'euros
Free cash flow: -153 millions d'euros
3 862 millions d'euros
Guidance from the release
First-half performance allows for an upward revision of the 2026 guidance; the trend since the start of the year confirms the continued momentum observed in 2025 and even shows performance that exceeded the Group's initial expectations
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
